These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 15043386)
21. [Contemporary control of biological warfare]. Płusa T; Jahnz-Rózyk K Pol Merkur Lekarski; 2002 Mar; 12(69):173-7. PubMed ID: 12053581 [TBL] [Abstract][Full Text] [Related]
22. Viral vectors for use in the development of biodefense vaccines. Lee JS; Hadjipanayis AG; Parker MD Adv Drug Deliv Rev; 2005 Jun; 57(9):1293-314. PubMed ID: 15935875 [TBL] [Abstract][Full Text] [Related]
23. [Viruses as biological weapons]. Akçali A Mikrobiyol Bul; 2005 Jul; 39(3):383-97. PubMed ID: 16358499 [TBL] [Abstract][Full Text] [Related]
24. Bioterrorism: class A agents and their potential presentations in immunocompromised patients. Richard JL; Grimes DE Clin J Oncol Nurs; 2008 Apr; 12(2):295-302. PubMed ID: 18390465 [TBL] [Abstract][Full Text] [Related]
25. Ability of physicians to diagnose and manage illness due to category A bioterrorism agents. Cosgrove SE; Perl TM; Song X; Sisson SD Arch Intern Med; 2005 Sep; 165(17):2002-6. PubMed ID: 16186470 [TBL] [Abstract][Full Text] [Related]
26. [Bioterrorism]. Sata T Nihon Hoigaku Zasshi; 2005 Oct; 59(2):119-25. PubMed ID: 16296383 [TBL] [Abstract][Full Text] [Related]
27. Anthrax. Wenner KA; Kenner JR Dermatol Clin; 2004 Jul; 22(3):247-56, v. PubMed ID: 15207306 [TBL] [Abstract][Full Text] [Related]
28. Radiology of biological weapons--old and the new? Ketai L; Tchoyoson Lim CC Semin Roentgenol; 2007 Jan; 42(1):49-59. PubMed ID: 17174174 [No Abstract] [Full Text] [Related]
29. Bioterriorism: from threat to reality. Atlas RM Annu Rev Microbiol; 2002; 56():167-85. PubMed ID: 12142472 [TBL] [Abstract][Full Text] [Related]
30. Weapons of mass destruction: biological. Moquin RR; Moquin ME Neurosurg Focus; 2002 Mar; 12(3):E2. PubMed ID: 16212312 [TBL] [Abstract][Full Text] [Related]
31. Drugs and vaccines for biological weapons. Med Lett Drugs Ther; 2001 Oct; 43(1115):87-9. PubMed ID: 11606896 [No Abstract] [Full Text] [Related]
32. Clinical management of potential bioterrorism-related conditions. Adalja AA; Toner E; Inglesby TV N Engl J Med; 2015 Mar; 372(10):954-62. PubMed ID: 25738671 [TBL] [Abstract][Full Text] [Related]
33. Vaccines against biologic agents: uses and developments. Ales NC; Katial RK Respir Care Clin N Am; 2004 Mar; 10(1):123-46. PubMed ID: 15062232 [TBL] [Abstract][Full Text] [Related]
34. Bacterial agents used for bioterrorism. Horn JK Surg Infect (Larchmt); 2003; 4(3):281-7. PubMed ID: 14588163 [TBL] [Abstract][Full Text] [Related]
35. Passive antibody administration (immediate immunity) as a specific defense against biological weapons. Casadevall A Emerg Infect Dis; 2002 Aug; 8(8):833-41. PubMed ID: 12141970 [TBL] [Abstract][Full Text] [Related]
37. Therapeutic options for diseases due to potential viral agents of bioterrorism. Bronze MS; Greenfield RA Curr Opin Investig Drugs; 2003 Feb; 4(2):172-8. PubMed ID: 12669378 [TBL] [Abstract][Full Text] [Related]
38. Bioterrorism's invisible threats: heightened awareness will help nurses identify real and suspected bioterrorism. Altman GB Nurs Manage; 2002 Jan; 33(1):43, 45-7. PubMed ID: 11984331 [TBL] [Abstract][Full Text] [Related]
39. The history of biologic warfare and bioterrorism. Jacobs MK Dermatol Clin; 2004 Jul; 22(3):231-46, v. PubMed ID: 15207305 [TBL] [Abstract][Full Text] [Related]